Clinical Trial Update: Cannabidiol for Bilateral Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating cannabidiol for reducing postoperative pain and opioid use after bilateral total knee arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Pain, Postoperative, Opioid Use | Phase 4 | Status: COMPLETED